CBIO
#3029
Crescent Biopharma, Inc. - Common Stock
15.8 8 USD
+0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.21%
Variación mensual
-10.94%
Variación en los últimos 6 meses
+26.84%
Cambio anual
+24.06%
Cierres anteriores
15.6 9
Open
15.8 8
Mínimo
15.8 6
High
15.9 3
Volumen
6
Financials
- Market Capitalization 437.84 M
- Employee 44
- Founded 2024
- CEO N/A
- Website www.crescentbiopharma.com
- Headquarter Cayman Islands
- FIGI N/A
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
1.75
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2140 |  MAZE Maze Therapeutics, Inc. - Common Stock | 30.21 USD | +3.53% | -9.50% | +24.17% | -32.91% | 1.67 B USD | ||
| 2867 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 10.34 USD | -0.96% | -13.04% | +8.61% | -39.35% | 559.79 M USD | ||
| 3120 |  UPB Upstream Bio, Inc. - Common Stock | 7.25 USD | -0.41% | -7.76% | +17.12% | -38.56% | 394.54 M USD | ||
| 3151 |  QTTB Q32 Bio Inc. - Common Stock | 19.75 USD | -7.62% | +42.50% | +54.54% | +872.91% | 334.89 M USD |